Skip to content
10-Q

Quarterly Report

COMPASS BIOTECHNOLOGIES INC.

0001477932-16-013931

← back to feed
Filed
Dec 5, 2016 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Oct 31, 2011 23.92M sh
Capex Q3 2011 · Oct 31, 2011 $2.91K
Operating Cash Flow Q3 2011 · Oct 31, 2011 −$251.83K
Operating Cash Flow Q3 2011 · Oct 31, 2011 −$1.95M
Operating Cash Flow Q3 2011 · Oct 31, 2010 −$236.96K
Cash And Equivalents Q3 2011 · Oct 31, 2011 $94
Cash And Equivalents Q3 2011 · Jan 31, 2011 $34.75K
Cash And Equivalents Q3 2011 · Oct 31, 2010 $81.54K
Cash And Equivalents Q3 2011 · Jan 31, 2010 $4.92K
Stockholders Equity Q3 2011 · Oct 31, 2011 −$261.92K
Stockholders Equity Q3 2011 · Jan 31, 2011 −$131.41K
Total Liabilities Q3 2011 · Oct 31, 2011 $964.4K
Total Liabilities Q3 2011 · Jan 31, 2011 $949.18K
Current Assets Q3 2011 · Oct 31, 2011 $64.94K
Current Assets Q3 2011 · Jan 31, 2011 $121.99K
Total Assets Q3 2011 · Oct 31, 2011 $702.48K
Total Assets Q3 2011 · Jan 31, 2011 $817.77K
Sga Expense Q3 2011 · Oct 31, 2011 $160.69K
Sga Expense Q3 2011 · Oct 31, 2011 $732.59K
Sga Expense Q3 2011 · Oct 31, 2011 $3.23M
Sga Expense Q3 2011 · Oct 31, 2010 $87.17K
Sga Expense Q3 2011 · Oct 31, 2010 $495.56K
Rd Expense Q3 2011 · Oct 31, 2011 $17.98K
Rd Expense Q3 2011 · Oct 31, 2011 $58.47K
Rd Expense Q3 2011 · Oct 31, 2011 $1.05M
Rd Expense Q3 2011 · Oct 31, 2010 $16.47K
Rd Expense Q3 2011 · Oct 31, 2010 $49.12K
Net Income Q3 2011 · Oct 31, 2011 −$215.99K
Net Income Q3 2011 · Oct 31, 2011 −$882.5K
Net Income Q3 2011 · Oct 31, 2011 −$4.88M
Net Income Q3 2011 · Oct 31, 2010 −$120.11K
Net Income Q3 2011 · Oct 31, 2010 −$664.75K
Operating Income Q3 2011 · Oct 31, 2011 −$215.99K
Operating Income Q3 2011 · Oct 31, 2011 −$907.76K
Operating Income Q3 2011 · Oct 31, 2011 −$4.85M
Operating Income Q3 2011 · Oct 31, 2010 −$120.11K
Operating Income Q3 2011 · Oct 31, 2010 −$593.79K